<code id='BD367B07EF'></code><style id='BD367B07EF'></style>
    • <acronym id='BD367B07EF'></acronym>
      <center id='BD367B07EF'><center id='BD367B07EF'><tfoot id='BD367B07EF'></tfoot></center><abbr id='BD367B07EF'><dir id='BD367B07EF'><tfoot id='BD367B07EF'></tfoot><noframes id='BD367B07EF'>

    • <optgroup id='BD367B07EF'><strike id='BD367B07EF'><sup id='BD367B07EF'></sup></strike><code id='BD367B07EF'></code></optgroup>
        1. <b id='BD367B07EF'><label id='BD367B07EF'><select id='BD367B07EF'><dt id='BD367B07EF'><span id='BD367B07EF'></span></dt></select></label></b><u id='BD367B07EF'></u>
          <i id='BD367B07EF'><strike id='BD367B07EF'><tt id='BD367B07EF'><pre id='BD367B07EF'></pre></tt></strike></i>

          leisure time

          leisure time

          author:leisure time    Page View:566
          JUUL store sign -- health coverage from STAT
          Stephanie Keith/Getty Images

          Documents released this week shed new light on an aggressive strategy from vape maker Juul to court Black leaders, including the Rev. Al Sharpton, to publicly support its e-cigarettes.

          Beginning in 2018, Juul executives, including the company’s CEO, discussed six- and seven-figure partnerships with civil rights organizations, one of which would have seen it send as much as $7 million to Sharpton’s group, according to internal emails and documents that were released this week as part of a legal settlement with the state of North Carolina.

          advertisement

          It’s not clear how much the company ultimately spent on the partnerships.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Guidelines to prevent youth baseball injuries need more muscle
          Guidelines to prevent youth baseball injuries need more muscle

          Apitcheratthe2018LittleLeagueWorldSeries.RobCarr/GettyImages“Weallknowthatweareinthemiddleofanepidem

          read more
          Eli Lilly reports tirzepatide MASH success during Q4 earnings
          Eli Lilly reports tirzepatide MASH success during Q4 earnings

          DarronCummings/APTheblockbusterweightlossanddiabetesdrugsoldbyEliLillyalsoappearstoimprovefattyliver

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          Eli Lilly reports tirzepatide MASH success during Q4 earnings

          DarronCummings/APTheblockbusterweightlossanddiabetesdrugsoldbyEliLillyalsoappearstoimprovefattyliver